These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15125310)

  • 1. [Experience with Risperidone in the treatment of institutionalized mentally retarded patients, with special reference to treatment of aggressive states].
    Hal V; Fehér L
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):19-25. PubMed ID: 15125310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone for controlling aggressive behavior in a mentally retarded child: a case report.
    Maneeton N; Intaprasert S; Srisurapanont M
    J Med Assoc Thai; 2001 Jun; 84(6):893-6. PubMed ID: 11556472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study.
    Amore M; Bertelli M; Villani D; Tamborini S; Rossi M
    J Intellect Disabil Res; 2011 Feb; 55(2):210-8. PubMed ID: 21129058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopharmacological therapy of self-injurious behavior in mentally retarded individuals].
    Hässler F; Fegert JM
    Nervenarzt; 1999 Nov; 70(11):1025-8. PubMed ID: 10603598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities and limits of treatment of aggressive behavior in patients with mental retardation with risperidone].
    Hässler F; Buchmann J; Bohne S
    Nervenarzt; 2002 Mar; 73(3):278-82. PubMed ID: 11963264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggression and schizophrenia: efficacy of risperidone.
    Buckley PF; Ibrahim ZY; Singer B; Orr B; Donenwirth K; Brar PS
    J Am Acad Psychiatry Law; 1997; 25(2):173-81. PubMed ID: 9213289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of borderline personality disorder with risperidone.
    Rocca P; Marchiaro L; Cocuzza E; Bogetto F
    J Clin Psychiatry; 2002 Mar; 63(3):241-4. PubMed ID: 11926724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
    Cohen SA; Ihrig K; Lott RS; Kerrick JM
    J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.
    Buitelaar JK
    J Child Adolesc Psychopharmacol; 2000; 10(1):19-26. PubMed ID: 10755578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
    Ruedrich SL; Swales TP; Rossvanes C; Diana L; Arkadiev V; Lim K
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):132-40. PubMed ID: 18197952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone for young children with mood disorders and aggressive behavior.
    Schreier HA
    J Child Adolesc Psychopharmacol; 1998; 8(1):49-59. PubMed ID: 9639079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacologic treatment of pathologic aggression.
    Fava M
    Psychiatr Clin North Am; 1997 Jun; 20(2):427-51. PubMed ID: 9196923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing behavior in mentally retarded residential populations.
    Deutsch SI
    Hosp Community Psychiatry; 1986 Mar; 37(3):221-2. PubMed ID: 2870016
    [No Abstract]   [Full Text] [Related]  

  • 17. Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: an open-label study.
    Spivak B; Mozes T; Mester R; Kodelik M; Weizman A
    J Child Adolesc Psychopharmacol; 2001; 11(3):279-84. PubMed ID: 11642477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone and explosive aggressive autism.
    Horrigan JP; Barnhill LJ
    J Autism Dev Disord; 1997 Jun; 27(3):313-23. PubMed ID: 9229261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.
    Cohen S; Glazewski R; Khan S; Khan A
    J Clin Psychiatry; 2001 Feb; 62(2):114-6. PubMed ID: 11247096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.